Edyta Zielinska | Nov 24, 2009 | 2 min read
A new type of cancer vaccine tested in mice appears to overcome some of the major hurdles associated with the treatment approach, according to a paper published today (November 25) in __Science Translational Medicine.__ The technology, which the researchers have already licensed to a biotechnology company, is being developed for clinical trials of melanoma. Immune cells are attracted by chemicals released by the polymer matrix (shown here) to sample the tumor molecules embedded within.Image: